How to administer thiamine injection?

Reading File
Finding Sources
Finding Sources
Searching the Web

how to administer thiamine injection IV IM dosing Wernicke's

Reading File
Reading File
Searching PubMed

thiamine Wernicke encephalopathy treatment

How to Administer a Thiamine Injection

Thiamine (vitamin B1) is given parenterally (IM or IV) when oral absorption is unreliable - most commonly for prophylaxis/treatment of Wernicke's encephalopathy in alcohol use disorder, malnutrition, hyperemesis, bariatric surgery patients, or before giving IV dextrose to an at-risk patient.

1. Before you give it - safety setup

  • Anaphylaxis risk: rare but real, especially with IV administration. Always give parenteral thiamine in a setting with resuscitation facilities available (adrenaline/epinephrine, oxygen, airway equipment) and observe the patient for at least 30 minutes after IV dosing - Fitzpatrick's Dermatology, p. 2241.
  • Check for known hypersensitivity to thiamine.
  • Give thiamine before or together with any glucose/dextrose infusion, never after - administering glucose first in a thiamine-deficient patient can precipitate or worsen Wernicke's encephalopathy - The Maudsley Prescribing Guidelines in Psychiatry, p. 512.

2. Route and dilution

Intramuscular (IM):
  • Draw up the prescribed dose and inject deep IM (e.g., gluteal or deltoid), rotating sites if giving repeated daily doses (IM thiamine can cause local pain/irritation).
  • Used in community settings or when IV access is not available.
Intravenous (IV):
  • Diluted thiamine (e.g., in 50-100 mL of normal saline or the manufacturer's diluent) and infused slowly, typically over 30 minutes, not given as a rapid IV push, to reduce the risk of anaphylactoid reaction.
  • If a smaller infusion volume is used (e.g., for fluid-restricted patients), flush the line at the same rate afterward to avoid underdosing.
  • Preferred route in hospital when Wernicke's encephalopathy is suspected or confirmed, since IM/oral absorption is unreliable in this setting.

3. Typical dosing (adult)

IndicationDoseRouteDuration
Prophylaxis, low risk (community)200-300 mg once dailyIMAt least 3 days
Prophylaxis, hospital setting200-300 mg once dailyIM or IV3-5 days, with daily review for signs of Wernicke's
Suspected/confirmed Wernicke's encephalopathy200-500 mg, 3 times daily (higher doses, e.g. 500 mg, used in alcohol-dependent patients; lower doses e.g. 200 mg in non-dependent patients)IV (over 30 min)Minimum 3-5 days or until no further clinical improvement
Step-down after parenteral course100-300 mg dailyOralContinued while at risk
Sources: The Maudsley Prescribing Guidelines in Psychiatry, 15th ed, p. 512; Fitzpatrick's Dermatology, p. 2241 (IV/IM 50-100 mg/day for 7-14 days for beriberi); consistent with clinical practice summaries from LITFL and EMCrit IBCC.

4. During and after administration

  • Monitor for local injection-site reactions (IM) and for signs of hypersensitivity (flushing, urticaria, wheeze, hypotension) during and shortly after IV administration.
  • Reassess daily for emergent signs of Wernicke's encephalopathy (confusion, ataxia, nystagmus/ophthalmoplegia) - if these appear, escalate to higher-dose IV thiamine on a medical unit, since untreated Wernicke's can progress to irreversible Korsakoff's syndrome - Maudsley Guidelines, p. 512.
  • Transition to oral maintenance thiamine once the parenteral course is complete and the patient can absorb orally.
A 2024 systematic review of Wernicke's encephalopathy diagnosis/treatment (PMID: 38306946) confirms there is still no single universally agreed dosing protocol, but supports early, high-dose parenteral (preferably IV) thiamine given before or with glucose whenever the diagnosis is suspected - consistent with the guidance above. This is a practical/administration overview; always follow your institution's specific protocol, the product's prescribing information, and involve a pharmacist/physician for dosing decisions in an actual patient.
This is a shared conversation. Sign in to Orris to start your own chat.